Cancer Epidemiology Biomarkers & Prevention, Vol 1, Issue 7 561-566, Copyright © 1992 by American Association for Cancer Research

ARTICLES

Cell proliferation in rat colon measured with bromodeoxyuridine, proliferating cell nuclear antigen, and [3H]thymidine

F Richter, A Richter, K Yang and M Lipkin
Irving Weinstein Laboratory for Gastrointestinal Cancer Prevention, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

Epithelial cell proliferation was studied in the normal colonic mucosa of 5-week-old Sprague-Dawley rats, comparing [3H]thymidine incorporation (group 1) with two newer proliferation markers, bromodeoxyuridine (group 2) and proliferating cell nuclear antigen (group 3). Microautoradiography (group 1) or immunoperoxidase assays (groups 2 and 3) were carried out. Cells were counted for positive reaction and position along 50 colonic crypt columns/animal. No significant differences were found in number or distribution of labeled epithelial cells in proliferative compartments in crypt columns of normal colonic mucosa; labeled cells were mainly in the lower 60% of colonic crypts. Thus, in this model, bromodeoxyuridine and proliferating cell nuclear antigens were comparable to [3H]thymidine as reliable markers of proliferating epithelial cells in rat colon.

This article has been cited by other articles:

				L. M. Brennan, E. M. Boncavage-Hennessey, M. J. Wolfe, M. W. Toussaint, W. E. Dennis, A. B. Rosencrance, and H. S. Gardner JR An In Vivo Method for Using 5-Bromo-2'-deoxyuridine (BrdU) as a Marker of Chemically-Induced Hepatocellular Proliferation in the Japanese Medaka (Oryzias latipes) Toxicol Pathol, April 1, 2001; 29(3): 387 - 397. [Abstract] [PDF]

				P. R. Holt Dairy Foods and Prevention of Colon Cancer: Human Studies J. Am. Coll. Nutr., October 1, 1999; 18(90005): 379S - 391. [Abstract] [Full Text] [PDF]